Cocirculation and replacement of SARS-CoV-2 variants in crowded settings and marginalized populations along the US-Mexico border

Autores/as

  • Antoine Chaillon Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States
  • Ietza Bojorquez Departamento de Estudios de Población, El Colegio de la Frontera Norte. Tijuana, Mexico
  • Jaime Sepúlveda Institute for Global Health Sciences, University of California. San Francisco, United States
  • Alicia Yolanda Harvey-Vera Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States/Facultad de Medicina, Universidad de Xochicalco. Tijuana, Mexico/United States-Mexico Border Health Commission. Tijuana, Mexico
  • M Gudelia Rangel Departamento de Estudios de Población, El Colegio de la Frontera Norte/United States-Mexico Border Health Commission. Tijuana, Mexico
  • Britt Skaathun Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States
  • Sanjay R Mehta Division of Infectious Diseases and Global Public Health, University of California San Diego/Veterans Affairs Health System. San Diego, United States
  • Caroline Ignacio Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States
  • Magali Porrachia Division of Infectious Diseases and Global Public Health, University of California San Diego/Veterans Affairs Health System. San Diego, United States
  • Davey M Smith Division of Infectious Diseases and Global Public Health, University of California San Diego/Veterans Affairs Health System. San Diego, United States
  • Steffanie A Strathdee Division of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States

DOI:

https://doi.org/10.21149/13980

Palabras clave:

SARS-CoV-2, lineages, recombination, genetic, drug users, emigrants and immigrants

Resumen

Objective. To interrogate the circulating SARS-CoV-2 lin­eages and recombinant variants in persons living in migrant shelters and persons who inject drugs (PWID). Materials and methods. We combined data from two studies with marginalized populations (migrants in shelters and persons who inject drugs) in Tijuana, Mexico. SARS-CoV-2 variants were identified on nasal swabs specimens and compared to publicly available genomes sampled in Mexico and California. Results. All but 2 of the 10 lineages identified were predomi­nantly detected in North and Central America. Discrepan­cies between migrants and PWID can be explained by the temporal emergence and short time span of most of these lineages in the region. Conclusion. The results illustrate the temporo-spatial structure for SARS-CoV-2 lineage dispersal and the potential co-circulation of multiple lineages in high-risk populations with close social contacts. These conditions create the potential for recombination to take place in the California-Baja California border.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Lemey P, Ruktanonchai N, Hong SL, Colizza V, Poletto C, Van den Broeck F, et al. Untangling introductions and persistence in COVID-19 resurgence in Europe. Nature. 2021;595(7869):713-7. https://doi.org/10.1038/s41586-021-03754-2

Kraemer MUG, Yang CH, Gutierrez B, Wu CH, Klein B, Pigott DM, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020;368(6490):493-7. https://doi.org/10.1126/science.abb4218

Hodcroft EB, Zuber M, Nadeau S, Vaughan TG, Crawford KHD, Althaus CL, et al. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature. 2021;595(7869):707-12. https://doi.org/10.1038/s41586-021-03677-y

Lemey P, Rambaut A, Bedford T, Faria N, Bielejec F, Baele G, et al. Unifying viral genetics and human transportation data to predict the global transmission dynamics of human influenza H3N2. PloS Pathog. 2014;10(2):e1003932. https://doi.org/10.1371/journal.ppat.1003932

Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020;5(11):1403-7. https://doi.org/10.1038/s41564-020-0770-5

Gutierrez B, Castelan-Sanchez HG, Candido DDS, Jackson B, Fleishon S, Houzet R, et al. Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America. Cell Host Microbe. 2022;30(8):1112-23.e3. https://doi.org/10.1016/j.chom.2022.06.010

Upshaw TL, Brown C, Smith R, Perri M, Ziegler C, Pinto AD. Social determinants of COVID-19 incidence and outcomes: A rapid review. PloS One. 2021;16(3):e0248336. https://doi.org/10.1371/journal.pone.0248336

Hayward SE, Deal A, Cheng C, Crawshaw A, Orcutt M, Vandrevala TF, et al. Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review. J Migr Health. 2021;3:100041. https://doi.org/10.1016/j.jmh.2021.100041

Lebano A, Hamed S, Bradby H, Gil-Salmeron A, Dura-Ferrandis E, Garces-Ferrer J, et al. Migrants’ and refugees’ health status and healthcare in Europe: a scoping literature review. BMC Public Health. 2020;20(1):1039. https://doi.org/10.1186/s12889-020-08749-8

Kondilis E, Papamichail D, McCann S, Orcutt M, Carruthers E, Veizis A, Hargreaves S. The impact of the COVID-19 pandemic on migrants, refugees and asylum Seekers in Greece: A retrospective analysis of national surveillance data from 2020. eClinicalMedicine. 2021;37:100958. https://doi.org/10.1016/j.eclinm.2021.100958

Bojorquez-Chapela I, Strathdee SA, Garfein RS, Benson CA, Chaillon A, Ignacio C, et al. The impact of the COVID-19 pandemic among migrants in shelters in Tijuana, Baja California, Mexico. BMJ Global Health. 2022;7(3):e007202. https://doi.org/10.1136/bmjgh-2021-007202

Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S. COVID-19 and addiction. Diabetes Metab Syndr. 2020;14(5):817-23. https://doi.org/10.1016/j.dsx.2020.06.008

Aponte-Melendez Y, Mateu-Gelabert P, Fong C, Eckhardt B, Kapadia S, Marks K. The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services. Harm Reduct J. 2021;18(1):118. https://doi.org/10.1186/s12954-021-00568-3

Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26(1):30-9. https://doi.org/10.1038/s41380-020-00880-7

Strathdee SA, Abramovitz D, Harvey-Vera A, Vera CF, Rangel G, Artamonova I, et al. Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana border region. PloS One. 2021;16(11):e0260286. https://doi.org/10.1371/journal.pone.0260286

Deiss R, Garfein RS, Lozada R, Burgos JL, Brouwer KC, Moser KS, et al. Influences of cross-border mobility on tuberculosis diagnoses and treatment interruption among injection drug users in Tijuana, Mexico. Am J Public Health. 2009;99(8):1491-5. https://doi.org/10.2105/ajph.2008.142166

Melo JS, Mittal ML, Horyniak D, Strathdee SA, Werb D. Injection drug use trajectories among migrant populations: a narrative review. Subs Use Misuse. 2018;53(9):1558-70. https://doi.org/10.1080/10826084.2017.1416404

Goldenberg S, Silverman J, Engstrom D, Bojorquez-Chapela I, Strathdee S. “Right Here is the Gateway”: Mobility, Sex Work Entry and HIV Risk Along the Mexico-U.S. Border. Int Migr. 2014;52(4):26-40. https://doi.org/10.1111/imig.12104

Strathdee SA, Lozada R, Ojeda VD, Pollini RA, Brouwer KC, Vera A, et al. Differential effects of migration and deportation on HIV infection among male and female injection drug users in Tijuana, Mexico. PLoS One. 2008;3(7):e2690. https://doi.org/10.1371/journal.pone.0002690

Strathdee SA, Lozada R, Pollini RA, Brouwer KC, Mantsios A, Abramovitz DA, et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquir Immune Defic Syndr. 2008;47(3):369-76. https://doi.org/10.1097/QAI.0b013e318160d5ae

Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nature Microbiol. 2020;5(11):1403-7. https://doi.org/10.1038/s41564-020-0770-5

Shu Y, McCauley J. GISAID: Global initiative on sharing all influenza data - from vision to reality. Euro Surveill. 2017;22(13):30494. https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494

Gutierrez B, Castelán-Sánchez HG, da Silva Candido D, Jackson B, Fleishon S, Ruis C, et al. Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America. Cell Host Microbe. 2022;30(8):1112-23. https://doi.org/10.1016/j.chom.2022.06.010

O’Toole Á, Hill V, Pybus OG, Watts A, Bogoch, II, Khan K, et al. Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2 with grinch. Wellcome Open Res. 2021;6:121. https://doi.org/10.12688/wellcomeopenres.16661.2

Gangavarapu K, Latif A, Mullen J, Alkuzweny M, Hufbauer E, Tsueng G, et al. Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutarions. 2022 [cited May 2022]. Available from: https://outbreak.info/

Argimón S, Abudahab K, Goater RJE, Fedosejev A, Bhai J, Glasner C, et al. Microreact: visualizing and sharing data for genomic epidemiology and phylogeography. Microb Genom. 2016;2(11). https://doi.org/10.1099/mgen.0.00009

Descargas

Publicado

2023-01-02

Cómo citar

1.
Chaillon A, Bojorquez I, Sepúlveda J, Harvey-Vera AY, Rangel MG, Skaathun B, Mehta SR, Ignacio C, Porrachia M, Smith DM, Strathdee SA. Cocirculation and replacement of SARS-CoV-2 variants in crowded settings and marginalized populations along the US-Mexico border. Salud Publica Mex [Internet]. 2 de enero de 2023 [citado 9 de junio de 2024];65(1, ene-feb):10-8. Disponible en: https://www.saludpublica.mx/index.php/spm/article/view/13980

Número

Vol. 65 Núm. 1, ene-feb (2023)

Sección

Artículo original

Licencia

Derechos de autor 2022 Salud Pública de México

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Al proponer un trabajo para su publicación, los autores aceptan las condiciones contenidas en las presentes normas y ceden a Salud Pública de México los derechos patrimoniales sobre el artículo en cuestión, a fin de que ésta lo edite, publique, reproduzca, difunda, comercialice, traduzca o autorice su traducción a cualquier idioma.

Los derechos transferidos incluyen la publicación del artículo por cualquier medio, sea éste impreso, magnético o electrónico, o por cualquier otro soporte o medio de difusión que exista o pueda crearse en el futuro, así como la realización de publicaciones mediante la concesión de licencias totales o parciales a terceros.

Los artículos aceptados serán publicados en Salud Pública de México bajo una licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional.

Los trabajos propuestos deberán ser originales e iné­ditos, y no podrán presentarse a ninguna otra revista mien­tras se encuentren sometidos a la consideración de Salud Pública de México.También se reciben trabajos completos publicados previamente en forma de resumen, o trabajos no publicados presentados en congresos o seminarios.

Todos los trabajos serán publicados con pleno co­nocimiento de los autores.

Los artículos firmados son responsabilidad de los autores y no necesariamente reflejan la opinión de la revista, del Instituto Nacional de Salud Pública o de la institución a la que están afiliados los autores.

Artículos más leídos del mismo autor/a

1 2 > >>